How do breast cancer clinical trials approach cardiovascular safety: targeted or generalized?

By sjmartinez • February 7, 2024

Hamid A, Fonarow GC, Butler J, Hall ME. How do breast cancer clinical trials approach cardiovascular safety: targeted or generalized? Cardiooncology. 2024 Feb 7;10(1):6. doi: 10.1186/s40959-024-00201-9. PMID: 38321579.

Tags: breast cancer, Cardiology/Epi, Cardiovascular safety, clinical trials, Prevent cardiotoxicity, Publications

David E. Haines, MD, September 1, 1954, to February 10, 2024

Daoud EG, Shivkumar K, Mehta NK. David E. Haines, MD, September 1, 1954, to February 10, 2024. Heart Rhythm. 2024 May;21(5):710-711. doi: 10.1016/j.hrthm.2024.03.016. PMID: 38692819.

Effects of Empagliflozin on vascular and skeletal mineralization in Hyperlipidemic mice

Kalanski S, Pradhan S, Hon A, Xia Y, Safvati N, Rivera JC, Lu M, Demer LL, Tintut Y. Effects of Empagliflozin on vascular and skeletal[...]

David E. Haines, MD, September 1, 1954, to February 10, 2024

Daoud EG, Shivkumar K, Mehta NK. David E. Haines, MD, September 1, 1954, to February 10, 2024. JACC Clin Electrophysiol. 2024 Apr 19:S2405-500X(24)00185-3. doi: 10.1016/j.jacep.2024.03.004.[...]